Literature DB >> 15845187

Constitutive (HO-2) and inducible (HO-1) haem oxygenase in pleomorphic adenomas of the human parotid: an immunocytochemical study.

Stephen Lo1, Silvana Di Palma, Hafsa Yusuf, Andrew W McCombe.   

Abstract

This study examines the expression HO-1 and HO-2 isozymes in human parotid pleomorphic adenomas. They are members of the heat shock protein family, and are thought to play a role in the regulation of tumoral blood flow. Immunocytochemistry using antibodies specific for HO-1 and HO-2 were undertaken in 12 pleomorphic adenoma specimens, all sections of which contained adjacent normal salivary tissue. Normal salivary gland acini and ducts displayed significantly stronger immunoreactivity for HO-2 compared to tumour cells (p < 0.001). Expression for HO-1 was minimal in both normal salivary gland acini and tumour cells with no difference (p = 1.000). However, positive staining for HO-1 was seen in normal salivary ducts and in pleomorphic adenomas showing ductal differentiation. In conclusion, this is the first study to examine the expression of HO-1 and HO-2 within normal salivary glands and pleomorphic adenomas. Our findings suggest that HO may be implicated in the pathogenesis of salivary pleomorphic adenomas.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15845187     DOI: 10.1258/0022215053561567

Source DB:  PubMed          Journal:  J Laryngol Otol        ISSN: 0022-2151            Impact factor:   1.469


  2 in total

Review 1.  Molecular chaperones in tumors of salivary glands.

Authors:  Charbel A Basset; Francesco Cappello; Francesca Rappa; Vincenzo Luca Lentini; Abdo R Jurjus; Everly Conway de Macario; Alberto J L Macario; Angelo Leone
Journal:  J Mol Histol       Date:  2020-04-16       Impact factor: 2.611

2.  Nuclear translocation of haeme oxygenase-1 is associated to prostate cancer.

Authors:  P Sacca; R Meiss; G Casas; O Mazza; J C Calvo; N Navone; E Vazquez
Journal:  Br J Cancer       Date:  2007-11-20       Impact factor: 7.640

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.